| Literature DB >> 31822263 |
Fukuan Du1,2, Yan Li3, Jing Shen3,4, Yueshui Zhao3,4, Parham Jabbarzadeh Kaboli3,4, Shixin Xiang3, Xu Wu3,4, Mingxing Li3,4, Jiangyao Zhou5, Yuan Zheng6, Tao Yi7, Xiang Li3, Jing Li8, Zhangang Xiao9,10, Qinglian Wen11.
Abstract
BACKGROUND: Fish immunity is not only affected by the innate immune pathways but is also triggered by stress. Transport and loading stress can induce oxidative stress and further activate the immune inflammatory response, which cause tissue damage and sudden death. Multiple genes take part in this process and some of these genes play a vital role in regulation of the immune inflammatory response and sudden death. Currently, the key genes regulating the immune inflammatory response and the sudden death caused by stress in Coilia nasus are unknown.Entities:
Keywords: Coilia nasus; Glyoxalase 1 gene; Immunity; Inflammation; Oxidative stress; Stress
Mesh:
Substances:
Year: 2019 PMID: 31822263 PMCID: PMC6902355 DOI: 10.1186/s12863-019-0795-z
Source DB: PubMed Journal: BMC Genet ISSN: 1471-2156 Impact factor: 2.797
Fig. 1Transport stress and Glo1 response in C. nasus. (a) Changes in the survival rate after transport stress. (b) Stress response elements (SREs) in the Glo1 genes of different species. (c) Glo1 mRNA expressions in the dead fish and surviving fish groups
Fig. 2Schematic diagram of the Glo1 gene structure and Southern blotting results. (a) Schematic diagram of the Glo1 gene structure. The full-length gene is 4356 bp long, with six exons and five introns. (b) Southern blotting results for Glo1 in C. nasus
Fig. 3Association analysis of Glo1 polymorphism and stress tolerance. (a) Two polymorphic loci (495 T/C and 504 G/A) in the Glo1 gene. (b) Analysis of paired-locus linkage disequilibrium of 495 T/C and 506G/A. (c) The mRNA expressions of the heterozygous genotype (TC/GA) and homozygous genotypes (CC/AA, TT/GG). (d) Protein expressions of the heterozygous genotype (TC/GA) and homozygous genotypes (CC/AA, TT/GG)
Association analysis of SNPs in Glo1 that confers stress tolerance
| Locus | Genotype | Dead | Survival | χ2 (P) |
|---|---|---|---|---|
| 495 T/C | CC | 6 (0.171) | 3 (0.158) | 6.240 (0.044) |
| TC | 17 (0.486) | 15 (0.789) | ||
| TT | 12 (0.343) | 1 (0.053) | ||
| 504G/A | AA | 12 (0.343) | 3 (0.158) | 13.095 (0.001) |
| GA | 10 (0.286) | 15 (0.789) | ||
| GG | 13 (0.371) | 1 (0.053) |
Fig. 4Comparison of the Glo1 amino acid sequences and three-dimensional protein structures predicted for the different Glo1 genotypes. (a) Comparison of the Glo1 amino acid sequences of different species. (b) Three-dimensional Glo1 protein structure corresponding to genotype 495 T/506G. (c) Three-dimensional Glo1 protein structure corresponding to genotypes 495C/506A
Fig. 5Glo1 mRNA and protein expression and the survival rate regulated by different ions. (a) Glo1 mRNA expression regulated by different ions. Data are expressed as the ratio of Glo1 mRNA expression in the brain to its expression in the C2 group (mean ± SD). Data with different superscript letters are significantly different (P < 0.05). C, control, no ions; S, sea salt; C2, control 2, no ions, 8 h after transport; Ga, Glo1 agonist, SEC; Na+, NaCl; Sor, sorbitol; Mg2+, MgCl2; K+, KCl; Ca2+, CaCl2. (b) Glo1 protein expression was regulated by different ions. (c) Changes in survival rate regulated by different ions. (d) Changes in survival rate regulated by different concentrations of NaCl. (e) Glo1 mRNA expression regulated by different concentrations of NaCl. Data are expressed as the ratio of Glo1 mRNA expression in the brain to its expression in the C group (mean ± SD). Data with * are significantly different (P < 0.05). C, no NaCl control; C4, no NaCl control after 4 h stress. The following are the 0.5, 1.0, 1.5, and 2.0% NaCl groups. (f) Glo1 protein expression was regulated by different concentrations of NaCl
Effects of Glo1-regulating reagents on the apoptosis pathway mediated by TNF-α
| LPO (nmol/mg) | TNFα (g/L) | Caspase 9 (IU/L) | Caspase 3 (IU/L) | Cytochrome c (nmol/L) | |
|---|---|---|---|---|---|
| Control 0 | 0.23 ± 0.08a | 2.47 ± 0.15a | 36.90 ± 2.45a | 42.66 ± 3.23a | 123.23 ± 4.05a |
| Control 8 | 0.97 ± 0.06b | 12.00 ± 0.23b | 90.89 ± 4.22b | 89.28 ± 3.45b | 435.34 ± 6.38b |
| Glo 1 agonists | 0.54 ± 0.07c | 3.32 ± 0.45c | 52.38 ± 3.13c | 48.58 ± 6.43a | 204.55 ± 12.45c |
| NaCl | 0.46 ± 0.04c | 2.49 ± 0.23a | 42.89 ± 3.13d | 49.46 ± 2.69c | 180.43 ± 5.34d |
| CaCl2 | 1.24 ± 0.05d | 11.56 ± 0.33b | 89.34 ± 6.19b | 98.33 ± 6.67d | 590.83 ± 14.65e |
| Mg Cl2 | 0.98 ± 0.04b | 12.03 ± 0.45b | 106.23 ± 10.48e | 89.45 ± 3.13b | 467.93 ± 7.12f |
| KCl | 0.73 ± 0.07e | 5.32 ± 0.43d | 80.78 ± 8.34b | 56.78 ± 4.78e | 304.43 ± 9.43g |
| Sorbitol | 0.50 ± 0.06c | 2.35 ± 0.33a | 38.49 ± 3.13a | 45.48 ± 7.29a | 178.93 ± 10.82d |
Values presented are the means of three replicates. Means in the same column with different superscript letters are significantly different (P < 0.05)
Effects of Glo1-regulating reagents on total antioxidant capacity (T-AOC), superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px)
| T-AOC (U/mg prot) | SOD (U/mg prot) | CAT(U/mg prot) | GSH-Px (U) | |
|---|---|---|---|---|
| Control 0 | 61.82 ± 7.08a | 0.64 ± 0.03a | 10.28 ± 1.23a | 5.50 ± 0.08a |
| Control 8 | 30.23 ± 4.23b | 0.54 ± 0.09b | 9.38 ± 2.08a | 25.45 ± 1.23b |
| Glo 1 agonists | 140.32 ± 4.32c | 0.73 ± 0.05c | 8.99 ± 1.56a | 8.24 ± 0.05c |
| NaCl | 163.26 ± 5.67d | 0.63 ± 0.06a | 10.23 ± 2.08a | 6.38 ± 0.06d |
| CaCl2 | 15.34 ± 2.34e | 0.45 ± 0.03b | 10.13 ± 1.46a | 42.34 ± 0.09e |
| Mg Cl2 | 19.32 ± 3.56e | 0.34 ± 0.04b | 11.34 ± 1.03a | 26.34 ± 1.32f |
| KCL | 18.23 ± 3.23e | 0.45 ± 0.05b | 8.92 ± 0.05b | 24.34 ± 0.05f |
| Sorbitol | 169.34 ± 2.33d | 0.63 ± 0.34a | 9.56 ± 0.09a | 6.78 ± 0.07d |
Values presented are the means of three replicates. Means in the same column with different superscript letters are significantly different (P < 0.05)
Fig. 6RNA sequencing data from TCGA and the GTEX database of cancer patients and normal samples were used to analyze the expression levels of Glo 1 genes in different kinds of cancers. The number of samples is shown in the figure
Fig. 7Kaplan-Meier survival curves of Glo1 genes in different kinds of cancers, based on the expression levels. The orange lines represent high expression and the green lines represent low expression
Sequences of primers used in this study
| CCACGCCTTACTGAAGCAGGCAAG | ||
| G1A | CCTGAGGTCTAAATCACCTG | |
| G2S | GCCAGGACTAGCCAAATTC | |
| G2A | CAGCTGGCACTCACCT | |
| G3S | TACACACGAATCCTTGGAATG | |
| G3A | GTGGAGTGGAGTTGCCTCCGCTG | |
| G4S | CTAGGAAGAGGCTACCTTTGGC | |
| G4A | CTTGCAGGCAGCATACACATCTG | |
| G5S | TGCTGTATTGCTCCTGTTAC | Glo1 amplification |
| G5A | CTTGCAGGCAGCATACACATCTG | |
| G6S | GTTTGCTCTCTGTAGGCCACA | Glo1 amplification |
| G6A | CACATATCACCAGTTCTCGTTACC | |
| 173S | CATTCCTCCAGAACCCCAGTAGTC | SNP genotyping |
| 173A | TGTGTGGCACCAAAGCCTCTAGTT | |
| Glo1-F | AAGACAGCCTGGACCTTCTC | Probe amplification |
| Glo1-R | ACGTGGGTCTGAGTTTCCAT | |
| 40S | ACATGGTGTCCATCTGCTCGTC | Glo1 RT-qPCR |
| 40A | TCGTTACCCTCTCCCACTAGTTTTT | |
| B1 | AACGGATCCGGTATGTGCAAAGC’ | Beta-actin RT-qPCR |
| B2 | GGGTCAGGATACCTCTCTTGCTCTG |
GenBank accession numbers of the Glo1 sequences used in this study
| | NC_006594.3 |
| | NC_000083.6 |
| | NC_006090.3 |
| | NW_004669463.1 |
| | NW_017608179.1 |
| | NW_016243793.1 |
| | LHQP01009933.1 |
| | NC_007124.5 |
| | NW_015557379.1 |
| | NC_008398.2 |
| | NT_078267.5 |
| Kluyveromyces lactis | NC_006042.1 |
| | NC_001145.3 |
| Schizosaccharomyces pombe | NC_003423.3 |
| | NC_017852.1 |
| | NW_001849812.1 |
| | NP_006699.2 |
| | XP_001173775.1 |
| | XP_001117098.1 |
| | XP_532129.3 |
| | NP_001076965.1 |
| | NP_001107032.1 |
| | NP_997477.1 |
| | XP_419481.1 |
| | NP_998316.1 |
| | XP_007238567.1 |
| | ACO09023.1 |
| | ACQ58210.1 |
| | ACH70673.1 |
| | XP_006779779.1 |
| | XP_004539831.1 |
| | XP_005913134.1 |
| | XP_007549146.1 |
| | XP_004067520.1 |
| | XP_003437619.1 |
| | XP_008403069.1 |